Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Foley

Showing results (81-90 of 275) with videos related to

Pageof 28
Sort By:
Mayo Clinic Proceedings|October 11, 2005
Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III studyRobert N Foley, Changchun Wang, Allan J Collins
Hemodialysis International. International Symposium on Home Hemodialysis|October 18, 2013
Perihospitalization patterns of hemoglobin levels and erythropoiesis-stimulating agent doses in US hemodialysis patients, 1998-2009Robert N Foley, Craig A Solid, Kenneth Lamb
Kidney International|April 17, 2004
Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United StatesShuling Li, Robert N Foley, Allan J Collins
Journal of the American Society of Nephrology : JASN|April 9, 2005
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 studyYelena Slinin, Robert N Foley, Allan J Collins
Lymphokine Research|January 1, 1989
The role of cytokines in the immunopathology of tuberculosis, and the regulation of agalactosyl IgGG A Rook, R A Attiyah, N Foley
Kidney International Reports|January 18, 2018
End-Stage Kidney Disease From Scleroderma in the United States, 1996 to 2012Donal J Sexton, Scott Reule, Robert N Foley
Journal of the American Society of Nephrology : JASN|April 24, 2001
Left ventricular hypertrophy in the renal patientRachel J Middleton, Patrick S Parfrey, Robert N Foley
Journal of the American Society of Nephrology : JASN|June 7, 2019
Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United StatesDaniel P Murphy, Paul E Drawz, Robert N Foley
Kidney International|October 10, 2002
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 StudyRobert N Foley, Charles A Herzog, Allan J Collins, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 20, 1998
Screening and treatment for cardiovascular disease in patients with chronic renal diseaseS W Murphy, R N Foley, P S Parfrey
Pageof 28

Showing results (81-90 of 275) with videos related to

Sort By:
Pageof 28
Mayo Clinic Proceedings|October 11, 2005
Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III studyRobert N Foley, Changchun Wang, Allan J Collins
Hemodialysis International. International Symposium on Home Hemodialysis|October 18, 2013
Perihospitalization patterns of hemoglobin levels and erythropoiesis-stimulating agent doses in US hemodialysis patients, 1998-2009Robert N Foley, Craig A Solid, Kenneth Lamb
Kidney International|April 17, 2004
Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United StatesShuling Li, Robert N Foley, Allan J Collins
Journal of the American Society of Nephrology : JASN|April 9, 2005
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 studyYelena Slinin, Robert N Foley, Allan J Collins
Lymphokine Research|January 1, 1989
The role of cytokines in the immunopathology of tuberculosis, and the regulation of agalactosyl IgGG A Rook, R A Attiyah, N Foley
Kidney International Reports|January 18, 2018
End-Stage Kidney Disease From Scleroderma in the United States, 1996 to 2012Donal J Sexton, Scott Reule, Robert N Foley
Journal of the American Society of Nephrology : JASN|April 24, 2001
Left ventricular hypertrophy in the renal patientRachel J Middleton, Patrick S Parfrey, Robert N Foley
Journal of the American Society of Nephrology : JASN|June 7, 2019
Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United StatesDaniel P Murphy, Paul E Drawz, Robert N Foley
Kidney International|October 10, 2002
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 StudyRobert N Foley, Charles A Herzog, Allan J Collins, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 20, 1998
Screening and treatment for cardiovascular disease in patients with chronic renal diseaseS W Murphy, R N Foley, P S Parfrey
Pageof 28